Safety and immunogenicity of malaria vectored vaccines given with routine expanded program on immunization vaccines in gambian infants and neonates: A randomized controlled trial

Frontiers in Immunology

Volumn 8, Issue NOV, 2017, Pages

  Mensah, Victorine A ^a   Roetynck, Sophie ^b   Kanteh, Ebrima K ^b   Bowyer, Georgina ^c   Ndaw, Amy ^a   Oko, Francis ^b   Bliss, Carly M ^c   Jagne, Ya Jankey ^b   Cortese, Riccardo ^d   Nicosia, Alfredo ^e,f,g   Roberts, Rachel ^h   D'Alessio, Flavia ⁱ   Leroy, Odile ⁱ   Faye, Babacar ^a   Kampmann, Beate ^b,j   Cisse, Badara ^a   Bojang, Kalifa ^b   Gerry, Stephen ^k   Viebig, Nicola K ⁱ   Lawrie, Alison M ^h   Clarke, Ed ^b   Imoukhuede, Egeruan B ^h   Ewer, Katie J ^c   Hill, Adrian V S ^c,h   Afolabi, Muhammed O ^b   more..

^a UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^b Medical Research Council Unit   (Gambia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d Keires AG   (Switzerland)

^e ReiThera ^*  (Italy)

^f CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h CHURCHILL HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

Cellular immune response; Clinical trials; Cytokines; Malaria; Vaccines

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA4 INTEGRIN; BCG VACCINE; CD28 ANTIGEN; CD4 ANTIGEN; CREATININE; DIPHTHERIA PERTUSSIS TETANUS HEPATITIS B VACCINE; GAMMA INTERFERON; HEMOGLOBIN; IMMUNOGLOBULIN G; INTERLEUKIN 2; MALARIA VACCINE; MODIFIED VACCINIA VIRUS ANKARA 5T4 VACCINE; STAPHYLOCOCCUS ENTEROTOXIN B; TUMOR NECROSIS FACTOR;

ANOPHELES GAMBIAE; ARTICLE; BLOOD CELL COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEVER; FLOW CYTOMETRY; HUMAN; HUMORAL IMMUNITY; IMPETIGO; INFANT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NEWBORN; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEPSIS; SUDDEN INFANT DEATH SYNDROME; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VACCINE IMMUNOGENICITY;

EID: 85034579090     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01551     Document Type: Article

References (34)

1. WHO. World Malaria Report 2016. Geneva: World Health Organization (2016)
2. Crompton PD, Pierce SK, Miller LH. Advances and challenges in malaria vaccine development. J Clin Invest (2010) 120(12):4168-78. doi:10.1172/JCI44423
3. Greenwood B, Targett G. Do we still need a malaria vaccine? Parasite Immunol (2009) 31(9):582-6. doi:10.1111/j.1365-3024.2009.01140.x
4. Greenwood B, Doumbo OK. Implementation of the malaria candidate vaccine RTS,S/AS01. Lancet (2016) 387(10016):318-9. doi:10.1016/S0140-6736(15)00807-7
5. Radosevic K, Rodriguez A, Lemckert A, Goudsmit J. Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects. Expert Rev Vaccines (2009) 8(5):577-92. doi:10.1586/erv.09.14
6. Rodriguez A, Mintardjo R, Tax D, Gillissen G, Custers J, Pau MG, et al. Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys. Vaccine (2009) 27(44):6226-33. doi:10.1016/j.vaccine.2009.07.106
7. Ratto-Kim S, Currier JR, Cox JH, Excler JL, Valencia-Micolta A, Thelian D, et al. Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens. PLoS One (2012) 7(9):e45840. doi:10.1371/journal.pone.0045840
8. O'Hara GA, Duncan CJ, Ewer KJ, Collins KA, Elias SC, Halstead FD, et al. Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector. J Infect Dis (2012) 205(5):772-81. doi:10.1093/infdis/jir850
9. Ewer KJ, O'Hara GA, Duncan CJ, Collins KA, Sheehy SH, Reyes-Sandoval A, et al. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. Nat Commun (2013) 4:2836. doi:10.1038/ncomms3836
10. Ogwang C, Afolabi M, Kimani D, Jagne YJ, Sheehy SH, Bliss CM, et al. Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults. PLoS One (2013) 8(3):e57726. doi:10.1371/journal.pone.0057726
11. Kimani D, Jagne YJ, Cox M, Kimani E, Bliss CM, Gitau E, et al. Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations. Mol Ther (2014) 22(11):1992-2003. doi:10.1038/mt.2014.109
12. Ogwang C, Kimani D, Edwards NJ, Roberts R, Mwacharo J, Bowyer G, et al. Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults. Sci Transl Med (2015) 7(286):286re5. doi:10.1126/scitranslmed.aaa2373
13. Afolabi MO, Tiono AB, Adetifa UJ, Yaro JB, Drammeh A, Nebie I, et al. Safety and immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants. Mol Ther (2016) 24(8):1470-7. doi:10.1038/mt.2016.83
14. Bliss CM, Drammeh A, Bowyer G, Sanou GS, Jagne YJ, Ouedraogo O, et al. Viral vector malaria vaccines induce high-level T cell and antibody responses in West African children and infants. Mol Ther (2017) 25(2):547-59. doi:10.1016/j.ymthe.2016.11.003
15. Ota MO, Odutola AA, Owiafe PK, Donkor S, Owolabi OA, Brittain NJ, et al. Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants. Sci Transl Med (2011) 3(88):88ra56. doi:10.1126/scitranslmed.3002461
16. McMurray DN. Do new TB vaccines have a place in the expanded program on immunization? Expert Rev Vaccines (2011) 10(12):1675-7. doi:10.1586/erv.11.144
17. Rts SCTP, Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BG, et al. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 367(24):2284-95. doi:10.1056/NEJMoa1208394
18. Mwesigwa J, Okebe J, Affara M, Di Tanna GL, Nwakanma D, Janha O, et al. On-going malaria transmission in The Gambia despite high coverage of control interventions: a nationwide cross-sectional survey. Malar J (2015) 14:314. doi:10.1186/s12936-015-0829-6
19. Odutola AA, Afolabi MO, Jafali J, Baldeh I, Owolabi OA, Owiafe P, et al. Haematological and biochemical reference values of Gambian infants. Trop Med Int Health (2014) 19(3):275-83. doi:10.1111/tmi.12245
20. Hanekom WA, Hughes J, Mavinkurve M, Mendillo M, Watkins M, Gamieldien H, et al. Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J Immunol Methods (2004) 291(1-2):185-95. doi:10.1016/j.jim.2004.06.010
21. de Voer RM, Schepp RM, Versteegh FG, van der Klis FR, Berbers GA. Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay. Clin Vaccine Immunol (2009) 16(3):433-6. doi:10.1128/CVI.00364-08
22. Elberse KE, Tcherniaeva I, Berbers GA, Schouls LM. Optimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccine. Clin Vaccine Immunol (2010) 17(4):674-82. doi:10.1128/CVI.00408-09
23. van Gageldonk PG, van Schaijk FG, van der Klis FR, Berbers GA. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J Immunol Methods (2008) 335(1-2):79-89. doi:10.1016/j.jim.2008.02.018
24. Roederer M, Nozzi JL, Nason MC. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A (2011) 79(2):167-74. doi:10.1002/cyto.a.21015
25. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol (2003) 112(5):973-80. doi:10.1016/j.jaci.2003.07.003
26. Robson KJ, Dolo A, Hackford IR, Doumbo O, Richards MB, Keita MM, et al. Natural polymorphism in the thrombospondin-related adhesive protein of Plasmodium falciparum. Am J Trop Med Hyg (1998) 58(1):81-9. doi:10.4269/ajtmh.1998.58.81
27. Ota MO, Vekemans J, Schlegel-Haueter SE, Fielding K, Whittle H, Lambert PH, et al. Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults. Vaccine (2004) 22(3-4):511-9. doi:10.1016/j.vaccine.2003.07.020
28. Vekemans J, Ota MO, Wang EC, Kidd M, Borysiewicz LK, Whittle H, et al. T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination. Clin Exp Immunol (2002) 127(3):495-8. doi:10.1046/j.1365-2249.2002.01788.x
29. Martinez X, Brandt C, Saddallah F, Tougne C, Barrios C, Wild F, et al. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc Natl Acad Sci U S A (1997) 94(16):8726-31. doi:10.1073/pnas.94.16.8726
30. Vekemans J, Amedei A, Ota MO, D'Elios MM, Goetghebuer T, Ismaili J, et al. Neonatal bacillus Calmette-Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol (2001) 31(5):1531-5. doi:10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1
31. Murray RA, Mansoor N, Harbacheuski R, Soler J, Davids V, Soares A, et al. Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8+ T cell response. J Immunol (2006) 177(8):5647-51. doi:10.4049/jimmunol.177.8.5647
32. Hermann E, Truyens C, Alonso-Vega C, Even J, Rodriguez P, Berthe A, et al. Human fetuses are able to mount an adultlike CD8 T-cell response. Blood (2002) 100(6):2153-8
33. Marchant A, Appay V, Van Der Sande M, Dulphy N, Liesnard C, Kidd M, et al. Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest (2003) 111(11):1747-55. doi:10.1172/JCI200317470
34. Hodgson SH, Ewer KJ, Bliss CM, Edwards NJ, Rampling T, Anagnostou NA, et al. Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals. J Infect Dis (2015) 211(7):1076-86. doi:10.1093/infdis/jiu579